Evosep introduces the Evosep Eno™, a revolutionary separation platform for LC-MS-based proteomics designed to meet the efficiency demands of modern laboratory management. This new instrument enhances throughput, accelerates workflows, and ensures precision—all critical to maintaining quality and scalability in drug discovery and clinical research environments.
By enabling analysis of over 500 samples daily and providing unmatched reproducibility across lab environments, Evosep Eno™ reduces analytical variability and ensures reliable outcomes. With its standardized workflows and consumable integration, lab managers benefit from reduced training requirements, lower risk of errors, and streamlined operations.
Why lab managers should consider Evosep Eno
- Accelerates throughput without sacrificing data quality—ideal for high-volume labs
- Ensures system-to-system reproducibility, reducing need for recalibration and validation
- Minimizes user intervention with integrated consumables and workflow automation
- Supports broader drug modality analysis through new SCIEX partnership
- Reduces operational bottlenecks by standardizing and simplifying LC-MS proteomics processes
Evosep Eno™ is a strategic investment for labs seeking robust, scalable solutions for advanced protein analysis and research efficiency.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. The original press release was provided by Evosep.
